Product NDC: | 66993-537 |
Proprietary Name: | R-Tanna |
Non Proprietary Name: | Phenylephrine Tannate, Chlorpheniramine Tannate |
Active Ingredient(s): | 4.5; 5 mg/5mL; mg/5mL & nbsp; Phenylephrine Tannate, Chlorpheniramine Tannate |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66993-537 |
Labeler Name: | Prasco Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20100203 |
Package NDC: | 66993-537-57 |
Package Description: | 473 mL in 1 BOTTLE, PLASTIC (66993-537-57) |
NDC Code | 66993-537-57 |
Proprietary Name | R-Tanna |
Package Description | 473 mL in 1 BOTTLE, PLASTIC (66993-537-57) |
Product NDC | 66993-537 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Phenylephrine Tannate, Chlorpheniramine Tannate |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20100203 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Prasco Laboratories |
Substance Name | CHLORPHENIRAMINE TANNATE; PHENYLEPHRINE TANNATE |
Strength Number | 4.5; 5 |
Strength Unit | mg/5mL; mg/5mL |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |